Digital Drugs: An anatomy of new medicines

摘要: Medicines are digitalized as aspects of their regulation and use embodied in or draw from interlinked computerized systems databases. This paper considers how this development changes the delivery health care, pharma industry, regulatory professional structures, it reconfigures material character drugs themselves. It draws on concept assemblage presenting a theory-based analysis that explores digi- tal drugs' ontological status including they embody benefit value. The ad- dresses three interconnected domains - (practice), research (episte- mology) (structures).